That's a possibility but the twist in this year CR's outlook is that it may be offset by a licencing deal with Permetrex, and/or could see a fund come in with a chunk of equity at a premium...(?).
Phase 1b Psoriasis Results - Very Soon, page-5
-
- There are more pages in this discussion • 68 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.025(7.04%) |
Mkt cap ! $687.8M | |||
| Open | High | Low | Value | Volume |
| 36.5¢ | 38.0¢ | 36.0¢ | $3.158M | 8.589M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 141840 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 135173 | 2 |
View Market Depth
| Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |